Also trades as: PTIXW (NASDAQ) · $vol 0M
PTIX OTC
Protagenic Therapeutics, Inc.
1W: +0.0%
1M: -26.3%
3M: +248.8%
YTD: +4.6%
1Y: -77.1%
3Y: -96.9%
5Y: -99.3%
$0.77
-0.01 (-0.78%)
Weekly Expected Move ±17.6%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.4M
52W Range0.128-3.77
Volume237
Avg Volume14,191
Beta1.07
Dividend—
Analyst Ratings
Company Info
CEOGaro H. Armen
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2021-04-27
Websitephytanix.com
149 Fifth Avenue
New York, NY 10010
US
New York, NY 10010
US
212 994 8200
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| ARMEN GARO H | P-Purchase | 20,000 | $0.65 | 2026-08-21 |
| ARMEN GARO H | P-Purchase | 16,634 | $0.59 | 2026-08-20 |
| ARMEN GARO H | P-Purchase | 2,700 | $0.35 | 2026-08-19 |
| ARMEN GARO H | P-Purchase | 2,220 | $0.32 | 2026-08-11 |
| ARMEN GARO H | P-Purchase | 685 | $0.22 | 2026-08-06 |